Simponi Aria is a prescription medicine used to treat the symptoms of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing, and Ulcerative Colitis. Simponi Aria may be used alone or with other medications.
Simponi Aria belongs to a class of drugs called Antipsoriatics, Systemic; DMARDs, TNF Inhibitors; Monoclonal Antibodies; Inflammatory Bowel Disease.
Golimumab is a human IgG1κ monoclonal antibody specific for human tumor necrosis factor-alpha (TNFα) that exhibits multiple glycoforms with molecular masses of approximately 150 to 151 kilodaltons. Golimumab was created using genetically engineered mice immunized with human TNF, resulting in an antibody with human-derived antibody variable and constant regions. Golimumab is produced by a recombinant cell line cultured by continuous perfusion and is purified by a series of steps that includes measures to inactivate and remove viruses.
The SIMPONI ARIA dosage regimen is 2 mg per kg given as an intravenous infusion over 30 minutes at weeks 0 and 4, and every 8 weeks thereafter.
Intravenous
60
Minutes
4
Weeks
The most common side effects include:
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
There are several programs patients can sign up for that will assist in treatment costs:
To learn more browse the resources below.
Contact us to chat with one of our helpful scheduling specialists!